Evidence reviews - November 2022
The following document contains the evidence that was used to develop the 2022 recommendations:
- Symptoms and signs
- Diagnostic accuracy of investigations
- Severity scoring systems
- Medical management strategies
- Monitoring for raised intracranial pressure and vasospasm
- Management of delayed cerebral ischemia
- Detecting hydrocephalus
- Managing hydrocephalus
- Detecting intracranial hypertension
- Managing intracranial hypertension
- Diagnostic imaging strategies
- Interventions to prevent re-bleeding
- Timing of interventions to prevent re-bleeding
- Risk of subsequent subarachnoid haemorrhage
- Imaging strategies for follow-up
- Non-culprit aneurysms
- Long-term medicines for reducing the risk of subsequent subarachnoid haemorrhage
- Long-term medication for managing the consequences of subarachnoid haemorrhage
- Patient information
- Investigating relatives of people with aneurysmal subarachnoid haemorrhage
This page was last updated: